Tag Archive for: Healthcare

Sector updates in March

Investment firms  Shanghai Fosun Pharmaceutical Co. Ltd has formed a partnership with seven other investors to form an investment fund that plans to invest ¥5 billion (US$695M) in local biotech and med-tech companies in Shenzhen, China UK healthcare investor RYSE Asset Management has closed a new fund to support start-ups involved in digital health and […]

From $1bn deals to Smart RNA – read our news roundup

AstraZeneca buys Novo Holdings portfolio company Amolyt in potential $1bn+ deal Novo Holdings A/S and Sofinnova Partners, two leading life sciences investors, made headlines on Thursday when portfolio company Amolyt Pharma entered into a definitive agreement to be acquired by AstraZeneca at a purchase price of US$800 million upfront and a potential milestone payment of […]

JPM ’24: The year’s healthcare barometer gives a more sunny outlook

The JPM Healthcare Conference of 2024 may not have witnessed a mega-merger announcement, but there is anticipation that the M&A market could pick up this year, with predictions that the economic headwinds of recent years could turn into tailwinds.  The recent M&A Firepower report from EY, formerly known as Ernst & Young, has forecast a […]

Optimum’s chosen charity: Ariana Smiles

In October, at our 15th Annual Healthcare Investor Conference, we announced our chosen charity for the year, Ariana Smiles. Ariana Smiles is a Special Named Fund at the Children’s Cancer and Leukaemia Group, raising funds for research into precision oncology medicine for children with leukaemia. Stephanie Seales Gabbitas and her husband Chris set up Ariana […]